* Bioventus Inc BVS.OQ reported quarterly adjusted
earnings of
26 cents per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for earnings of
18 cents per share.
* Revenue rose 32.3% to $130.41 million from a year ago;
analysts
expected $130.29 million.
* Bioventus Inc's reported EPS for the quarter was a loss of
1
cent.
* The mean earnings estimate of analysts had fallen by
about 14.1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Bioventus Inc shares had fallen by 4.3% this quarter.
* The company reported a quarterly loss of $364 thousand.
* Wall Street's median 12-month price target for Bioventus
Inc is
$20.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated March 10 at 03:14 p.m. All
figures in US dollars unless otherwise stated